Global Hormone Replacement Therapy Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

Description

List of Tables

The global demand for Hormone Replacement Therapy Market is presumed to reach the market size of nearly USD 45.55 BN by 2030 from USD 23.68 BN in 2022 with a CAGR of 8.52% under the study period 2023 - 2030.

Hormone replacement therapy (HRT) is a therapy used to treat women suffering from menopause issues. The harmones in such pateints are at inadequate levels compared to those required for the normal physiology of the human body. Hormone replacement therapy improves and extends the lives of many older women, whether initiated at menopause or much later. Hormone replacement therapy helps older women maintain their estrogen levels.

MARKET DYNAMICS:

A surge in menopausal discomfort and increased awareness about post-menopausal issues among women are expected to influence the hormone replacement therapy market growth to a great extent. The growth in the geriatric population is another reason for high demand of this therapy. Along with this, the launch of new hormone replacement therapy products is anticipated to drive market growth. Furthermore, the technological innovations in drug delivery systems could also positively impact the hormone replacement therapy market in the next few years. In addition, increased awareness about hormone replacement therapy is also expected to drive market growth. However, the high price associated with hormonal replacement therapy treatment may hamper the market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of hormone replacement therapy. The growth and trends of hormone replacement therapy industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the hormone replacement therapy market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

Estrogen And Progesterone Replacement Therapy
Human Growth Hormone (HGH) Replacement Therapy
Thyroid Hormone Replacement Therapy
Testosterone Replacement Therapy
Parathyroid Hormone Replacement

By Route Of Administration

Oral
Parenteral
Transdermal
Others

By Disease Type

Menopause
Hypothyroidism
Male Hypogonadism
Growth Hormone Deficiency
Hypoparathyroidism

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Hormone Replacement Therapy market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the hormone replacement therapy market include Bayer AG, Pfizer Inc., Merck & Co. Inc., Viatris Inc., Novo Nordisk A/S, Eli Lilly and Company, F. Hoffmann-La Roche Ltd, Noven Pharmaceuticals Inc., ASCEND Therapeutics US LLC., AbbVie Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Product Code: VMR11218811

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . HORMONE REPLACEMENT THERAPY - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product
- 3.7.2 Market Attractiveness Analysis By Route Of Administration
- 3.7.3 Market Attractiveness Analysis By Disease Type
- 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL HORMONE REPLACEMENT THERAPY MARKET ANALYSIS BY PRODUCT

6.1 Overview by Product
6.2 Historical and Forecast Data
6.3 Analysis by Product
6.4 Estrogen and Progesterone Replacement Therapy Historic and Forecast Sales by Regions
6.5 Human Growth Hormone (HGH) Replacement Therapy Historic and Forecast Sales by Regions
6.6 Thyroid Hormone Replacement Therapy Historic and Forecast Sales by Regions
6.7 Testosterone Replacement Therapy Historic and Forecast Sales by Regions
6.8 Parathyroid Hormone Replacement Historic and Forecast Sales by Regions

7 . GLOBAL HORMONE REPLACEMENT THERAPY MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

7.1 Overview by Route Of Administration
7.2 Historical and Forecast Data
7.3 Analysis by Route Of Administration
7.4 Oral Historic and Forecast Sales by Regions
7.5 Parenteral Historic and Forecast Sales by Regions
7.6 Transdermal Historic and Forecast Sales by Regions
7.7 Others Historic and Forecast Sales by Regions

8 . GLOBAL HORMONE REPLACEMENT THERAPY MARKET SALES ANALYSIS BY DISEASE TYPE

8.1 Overview by Disease Type
8.2 Historical and Forecast Data
8.3 Analysis by Disease Type
8.4 Menopause Historic and Forecast Sales by Regions
8.5 Hypothyroidism Historic and Forecast Sales by Regions
8.6 Male Hypogonadism Historic and Forecast Sales by Regions
8.7 Growth Hormone Deficiency Historic and Forecast Sales by Regions
8.8 Hypoparathyroidism Historic and Forecast Sales by Regions

9 . GLOBAL HORMONE REPLACEMENT THERAPY MARKET SALES ANALYSIS BY GEOGRAPHY

9.1. Regional Outlook Sales Analysis
9.2. Introduction Sales Analysis
9.3. North America Sales Analysis
- 9.3.1. Overview, Historic and Forecast Sales Analysis
- 9.3.2. North America By Segment Sales Analysis
- 9.3.3. North America By Country Sales Analysis
- 9.3.4. United State Sales Analysis
- 9.3.5. Canada Sales Analysis
- 9.3.6. Mexico Sales Analysis
9.4. Europe Sales Analysis
- 9.4.1. Overview, Historic and Forecast Sales Analysis
- 9.4.2. Europe by Segment Sales Analysis
- 9.4.3. Europe by Country Sales Analysis
- 9.4.4. United Kingdom Sales Analysis
- 9.4.5. France Sales Analysis
- 9.4.6. Germany Sales Analysis
- 9.4.7. Italy Sales Analysis
- 9.4.8. Russia Sales Analysis
- 9.4.9. Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
- 9.5.1. Overview, Historic and Forecast Sales Analysis
- 9.5.2. Asia Pacific by Segment Sales Analysis
- 9.5.3. Asia Pacific by Country Sales Analysis
- 9.5.4. China Sales Analysis
- 9.5.5. India Sales Analysis
- 9.5.6. Japan Sales Analysis
- 9.5.7. South Korea Sales Analysis
- 9.5.8. Australia Sales Analysis
- 9.5.9. Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
- 9.6.1. Overview, Historic and Forecast Sales Analysis
- 9.6.2. Latin America by Segment Sales Analysis
- 9.6.3. Latin America by Country Sales Analysis
- 9.6.4. Brazil Sales Analysis
- 9.6.5. Argentina Sales Analysis
- 9.6.6. Peru Sales Analysis
- 9.6.7. Chile Sales Analysis
- 9.6.8. Rest of Latin America Sales Analysis
9.7. Middle East & Africa Sales Analysis
- 9.7.1. Overview, Historic and Forecast Sales Analysis
- 9.7.2. Middle East & Africa by Segment Sales Analysis
- 9.7.3. Middle East & Africa by Country Sales Analysis
- 9.7.4. Saudi Arabia Sales Analysis
- 9.7.5. UAE Sales Analysis
- 9.7.6. Israel Sales Analysis
- 9.7.7. South Africa Sales Analysis
- 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE HORMONE REPLACEMENT THERAPY COMPANIES

10.1. Hormone Replacement Therapy Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments

11 . COMPANY PROFILES OF HORMONE REPLACEMENT THERAPY INDUSTRY

11.1. Top 10 Company Share Analysis
11.2. Market Concentration Rate
11.3. Bayer AG
- 11.3.1. Company Overview
- 11.3.2. Company Revenue
- 11.3.3. Products
- 11.3.4. Recent Developments
11.4. Pfizer Inc.
- 11.4.1. Company Overview
- 11.4.2. Company Revenue
- 11.4.3. Products
- 11.4.4. Recent Developments
11.5. Merck & Co. Inc.
- 11.5.1. Company Overview
- 11.5.2. Company Revenue
- 11.5.3. Products
- 11.5.4. Recent Developments
11.6. Viatris Inc.
- 11.6.1. Company Overview
- 11.6.2. Company Revenue
- 11.6.3. Products
- 11.6.4. Recent Developments
11.7. Novo Nordisk A/S
- 11.7.1. Company Overview
- 11.7.2. Company Revenue
- 11.7.3. Products
- 11.7.4. Recent Developments
11.8. Eli Lilly and Company
- 11.8.1. Company Overview
- 11.8.2. Company Revenue
- 11.8.3. Products
- 11.8.4. Recent Developments
11.9. F. Hoffmann-La Roche Ltd
- 11.9.1. Company Overview
- 11.9.2. Company Revenue
- 11.9.3. Products
- 11.9.4. Recent Developments
11.10. Noven Pharmaceuticals Inc.
- 11.10.1. Company Overview
- 11.10.2. Company Revenue
- 11.10.3. Products
- 11.10.4. Recent Developments
11.11. ASCEND Therapeutics US LLC.
- 11.11.1. Company Overview
- 11.11.2. Company Revenue
- 11.11.3. Products
- 11.11.4. Recent Developments
11.12. AbbVie Inc.
- 11.12.1. Company Overview
- 11.12.2. Company Revenue
- 11.12.3. Products
- 11.12.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies